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INTRODUCTION
Whole body iodine-131 (I-131) scan remains the mainstay
for the detection of recurrent or metastatic lesions of patients
with well-differentiated thyroid cancer. The presence of uptake
outside the areas of physiologic elimination such as salivary
glands, nasopharynx, urinary bladder, and stomach is sugges-
tive of metastasis. However, many false-positive findings on
I-131 diagnostic and therapeutic scans have been reported
(1-8). It is very important to recognize false positive findings
to avoid unnecessary ablation treatment.
Previously, gallbladder localization of I-131 during post-
therapy scan of well-differentiated thyroid cancer has been
described (9, 10). However, no other study has reported nor-
mal gallbladder accumulation of I-131. We report a case of
marked I-131 accumulation in normal gallbladder and this
is the first report of normal gallbladder visualization in the
absence of morphologic or functional abnormality (chronic
cholecystitis, septated, or hypokinetic gallbladder) on post-
I-131 therapy scan.
CASE REPORT
A 46-yr-old woman had a history of papillary thyroid can-
cer for which she had undergone total thyroidectomy. After
total thyroidectomy, diagnostic whole body I-131 scan was
performed. Forty-eight hours after the oral administration of
a 111 MBq diagnostic dose of I-131 scan revealed thyroid
remnants with regional lymph node metastasis and no abnor-
mal focal hepatic accumulation. Blood analyses showed thy-
roglobulin <1.0 ng/mL and 10.2 U/mL of anti-thyroglobu-
lin antibody. After a 4-week period of thyroid hormone with-
drawal and limited ingestion of iodine containing foods, she
was hospitalized for the radioiodine treatment for regional
lymph node metastasis. She was received an ablative dose of
3.7 GBq of I-131. The whole body scans performed at 7 day
showed areas of intense iodine accumulation in the thyroid
bed and mild, diffuse hepatic uptake with a focus of marked-
ly intense activity in the right hepatic lobe. In the right lat-
eral of abdomen image, the iodine avid area in the liver was
consistent with the location of gallbladder (Fig. 1). Another
at 14 day whole body I-131 scan also showed sustained aci-
tivity in gallbladder (Fig. 2). Abdominal ultrasound was per-
formed and showed normal hepatic parenchyma and gallblad-
der (Fig. 3). There was no abnormal echo in gallbladder to
suggest the presences of gallstone, inflammation, and meta-
stasis.
DISCUSSION
Whole body I-131 scan is a well-established imaging method
for the detection of metastatic or residual tumor sites in patients
with well-differentiated thyroid cancer. However, there are
many potential causes of false-positive I-131 scan findings
(1-8). False positive results may be caused by a wide variety
of non-thyroidal neoplasms, which can concentrate radio-
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Whole body iodine-131 scan is a well-established imaging method for the detec-
tion of metastatic or residual tumor sites in patients with well-differentiated thyroid
cancer. Many false-positive iodine-131 scan findings mimicking metastatic thyroid
cancer have long been reported. The authors describe a false positive uptake in
normal gallbladder on post-ablative iodine-131 scan in a patient with papillary thy-
roid cancer. This finding should be considered to be another possible false-posi-
tive finding on iodine-131 whole body scan.
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iodine or from skin contaminated by urine, sweat, or saliva.
Several organs are capable of trapping iodine, including the
salivary glands, gastric mucosa, choroids plexus, mammary
glands, and renal cysts or pericardial effusion. Brucker-Davis
et al. classified many false-positive findings into four main
groups: elimination of iodine through body fluids, infection
or inflammation, cyst or transduates, and non-thyroidal tumors
(11). 
Diffuse hepatic uptake of I-131 is a relatively common find-
ing during whole body imaging. This uptake may reflect both
I-131 liver blood pool activity as well as the physiologic hep-
atocellular concentration of I-131 labeled proteins and L-thy-
roxine (T4) produced by functioning thyroid tissue. The liver
is major organ in the metabolism of thyroid hormone. It active-
ly concentrates T4 and deiodinates it to T3. The liver is respon-
sible for 40% of T4 deiodination occurring in the whole of
the body and 70% of T3 production. Approximately 35%
of exchangeable body T4 and approximately 5% of T3 are
within the liver (12). The high incidence of diffuse hepatic
uptake in cases of high doses of I-131 post-therapy scan can
be explained by the fact that radiolabeled thyroid hormones
are accumulated in the liver in patients with remnant thy-
roid tissues.
It is sometimes difficult to differentiate diffuse hepatic up-
take and true hepatic metastasis. True hepatic metastases are
typically seen as focal uptakes: the uptake by hepatic metas-
tasis occurs earlier, with a time sequence similar to that of
uptake by the thyroid or other metastases. 
Thyroid hormones undergo metabolic degradation and
excretion in conjugated form into the gut. Hence, I-131 up-
take by the liver several days after I-131 administration is
an index of the amount of functioning tissue present (8, 9,
13, 14). The gallbladder may occasionally be depicted when
biliary excretion is extensive (8, 9). 
Previously, gallbladder localization of I-131 during post-
therapy scan has been described (9, 10). Two of these cases of
patients had chronic cholecystitis. However, no other study
has reported normal gallbladder accumulation of I-131 dur-
ing post-ablative I-131 scan of thyroid cancer. According to
Achong et al. (9), gallbladder visualization is likely a function
of both the dose and the timing of the scan relative to I-131
administration. In our case, the gallbladder was seen 1 and
2 weeks after administration of high dose of I-131. However,
it was not seen at 48 hr after low dose I-131 diagnostic scan.
The gallbladder may have been seen if post-treatment I-131
scan had been performed at 48 hr instead of 1 and 2 weeks.
Also, persistent gallbladder activity may be explained by
abnormalities in both gallbladder morphology and function-
al dynamics such as septated hypokinetic and septated gall-
bladder with stone and/or chronic cholecystitis (15). Although,
the functional study of gallbladder such as gallbladder ejec-
tion fraction measurement was not performed in this case, the
ultrasound and clinical information did not show any mor-
phological and underlying gallbladder disease. 
This article documents the first report of I-131 radioiodine
retention in the normal gallbladder that is not associated with
Fig. 1. Post-ablative I-131 whole body scan at 7 day shows an
intense accumulation in gallbladder.
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Fig. 2. Iodine-131 whole body scan at 14 day shows sustained
activity in the gallbladder.
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Fig. 3. Abdominal ultrasound reveals normal liver and gallblad-
der. There is no abnormal echo in the gallbladder to suggest the
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gross structural and functional abnormalities. Although this
is a rare finding, and the exact mechanism is unknown, it
should be considered into the possible false positive findings
of I-131 whole body scan. 
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